BVAXF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
GSGTF
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Ad is loading...

BVAXF vs GSGTF

Header iconBVAXF vs GSGTF Comparison
Open Charts BVAXF vs GSGTFBanner chart's image
BioVaxys Technology
Price$0.04
Change-$0.00 (-0.00%)
Volume$288.13K
CapitalizationN/A
Gensight Biologics SA
Price$0.32
Change-$0.00 (-0.00%)
Volume$250
CapitalizationN/A
View a ticker or compare two or three
BVAXF vs GSGTF Comparison Chart
Loading...
VS
BVAXF vs. GSGTF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVAXF is a Buy and GSGTF is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (BVAXF: $0.04 vs. GSGTF: $0.32)
Brand notoriety: BVAXF and GSGTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVAXF: 86% vs. GSGTF: 100%
Market capitalization -- BVAXF: $10.99M vs. GSGTF: $32.49M
BVAXF [@Biotechnology] is valued at $10.99M. GSGTF’s [@Biotechnology] market capitalization is $32.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVAXF’s FA Score shows that 0 FA rating(s) are green whileGSGTF’s FA Score has 0 green FA rating(s).

  • BVAXF’s FA Score: 0 green, 5 red.
  • GSGTF’s FA Score: 0 green, 5 red.
According to our system of comparison, BVAXF is a better buy in the long-term than GSGTF.

Price Growth

BVAXF (@Biotechnology) experienced а +1.64% price change this week, while GSGTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
GSGTF($32.5M) has a higher market cap than BVAXF($11M). BVAXF YTD gains are higher at: -11.951 vs. GSGTF (-31.915).
BVAXFGSGTFBVAXF / GSGTF
Capitalization11M32.5M34%
EBITDA-5.67MN/A-
Gain YTD-11.951-31.91537%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
GSGTF: Fundamental Ratings
GSGTF
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and GSGTF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and GSGTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
+5.40%
GSGTF - BVAXF
27%
Poorly correlated
N/A
EDSA - BVAXF
21%
Poorly correlated
-2.16%
SQZB - BVAXF
14%
Poorly correlated
N/A
INM - BVAXF
12%
Poorly correlated
+4.16%
OLMA - BVAXF
9%
Poorly correlated
+5.58%
More

GSGTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSGTF has been loosely correlated with HRTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GSGTF jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSGTF
1D Price
Change %
GSGTF100%
N/A
HRTX - GSGTF
44%
Loosely correlated
+3.89%
RPTX - GSGTF
33%
Loosely correlated
+1.79%
GOSS - GSGTF
29%
Poorly correlated
+0.21%
CMMB - GSGTF
29%
Poorly correlated
-3.82%
BVAXF - GSGTF
28%
Poorly correlated
+5.40%
More